ENTITY
WuXi AppTec

WuXi AppTec (603259 CH)

363
Analysis
Health Care • China
WuXi AppTec Co., Ltd. manufactures medical products. The Company produces biological agents, antibodies, biological diagnostic reagents, and other products. WuXi AppTec also provides biological analysis, technical study, and other services.
more
bearish•Quantitative Analysis
•05 Nov 2023 10:05

HK Short Interest Weekly: Yankuang Energy, CCB, Bidu, Petrochina

We analyzed the latest HK SFC report for aggregate short position as of Oct 27th and highlight short interest changes in Yankuang Energy, CCB,...

Logo
572 Views
Share
bullish•Wuxi Biologics
•05 Nov 2023 08:25

ECM Weekly (5th Nov 2023)- Midea, WuxiXDC, Cello, Honasa, Qyuns, Ecopro, Lalatech, Mankind, TWE, VNT

Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.

Logo
541 Views
Share
bearish•WuXi AppTec
•02 Nov 2023 08:55

WuXi AppTec (2359.HK/603259.CH) 23Q3 - Will the TIDES Business Turn the Tide?

WuXi AppTec received Lilly's GLP-1 order, but it's too small to guarantee the reversal logic.23Q3 results sounded an alarm for investors.The savior...

Logo
643 Views
Share
bullish•WuXi AppTec
•01 Nov 2023 18:52•Broker

WuXi AppTec (603259 CH) – Peptide Business Becoming a New Growth Driver

WuXi AppTec reported 3Q23 revenue of RMB10,670mn, up 0.3% YoY, and attributable recurring net income of RMB2,948mn, up 23.8% YoY

Logo
292 Views
Share
bearish•WuXi XDC Cayman
•01 Nov 2023 18:21

WuXi XDC IPO: The Bear Case

The bear case rests on margins on a downward trend, large customer concentration, high related party transactions and volatile FCF generation.

Logo
613 Views
Share
x